Navigation Links
Highlights from the March GIE: Gastrointestinal Endoscopy special issue on colorectal cancer
Date:3/19/2013

OAK BROOK, Ill. March 19, 2013 In recognition of National Colorectal Cancer Awareness Month, GIE: Gastrointestinal Endoscopy has published a special issue for March on colorectal cancer. The issue includes a practical guide for approaching and managing serrated colon polyps, one of the most common types of polyps, and a study on reducing postpolypectomy bleeding with prophylactic clip closure. GIE: Gastrointestinal Endoscopy is the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).

"The cutting edge of serrated polyps: a practical guide to approaching and managing serrated colon polyps"

Colonoscopy with detection and removal of colonic polyps is the foundation of colorectal cancer screening and surveillance programs. However, different types of colonic polyps have different malignant potential and recommendations for removal and follow-up surveillance varies depending on the type of polyp.

The most common colonic polyps include the conventional adenomas (tubular, tubulovillous, and villous adenomas which are precancerous polyps) and serrated polyps. Serrated polyps account for as many as 36 percent of colonic polyps. Initially the hyperplastic (benign) polyp was the only recognized serrated polyp. Today, the term serrated polyp is recognized as a general term describing a heterogeneous family of polyps with distinct molecular underpinnings, clinicopathologic features, and a varied capacity for malignant potential. In this review article from Christina A. Arnold, MD, Ohio State University, Columbus, and colleagues, the salient clinicopathologic features of serrated polyps and practical management recommendations are discussed.

The location and size of the serrated polyp are extremely helpful in determining the type of serrated polyp for the clinician and pathologist, therefore both should be documented. As conventional endoscopic techniques alone are unable to reliably diagnose polyps, histologic evaluation remains the criterion standard for accurate diagnosis. The most important type of serrated polyp is the sessile serrated adenoma/polyp (SSA/P). The prevalence of SSA/Ps ranges from one percent to nine percent of all colonic polyps. SSA/Ps are most commonly found in women, unlike the male-predominant conventional adenomas. Risk factors for SSA/Ps (and conventional adenomas) include older age, sex, smoking, and obesity; the latter two risk factors also independently predict large (>10 mm) SSA/Ps. Importantly, patients with SSA/Ps are more likely to have a greater polyp burden and synchronous and metachronous neoplastic lesions than patients without SSA/Ps. In addition, the progression from SSA/P with cytologic dysplasia to invasive carcinoma (cancer) may be relatively rapid. Complete removal of polyps, particularly small, flat, right-sided polyps (such as SSA/Ps) is challenging and associated with the development of interval carcinoma, likely through missing or incompletely removing the precursor lesion.

In September 2012, the U.S. Multi-Society Task Force on CRC (colorectal cancer) released updated guidelines for colonoscopy surveillance with a much-needed expansion on the management of serrated polyps. In addition to the U.S. Multi-Society Task Force guidelines, an expert consensus opinion was separately published in 2012 based on an expert panel discussion and review of advancements and insights in the serrated polyp literature. The 2012 guidelines have placed serrated polyps >10 mm or with cytologic dysplasia in the same surveillance category as high-risk adenomas with a three-year surveillance interval. The guidelines also advise a one-year surveillance interval for serrated polyposis (formerly "hyperplastic polyposis") a phenotypically variable condition associated with increased serrated polyps and an up to nearly 40 percent risk of colorectal cancer.

The expert consensus opinions recommend at least five-year endoscopic surveillance intervals for first-degree relatives of patients with serrated polyposis, starting at age 40 or 10 years younger than the age at diagnosis of the affected relative. Among the key management recommendations discussed in the guide for approaching and managing serrated colon polyps is the removal of serrated polyps. Given the malignant potential and that SSA/Ps are most often flat with indistinct borders, complete endoscopic resection (removal) is critical. When SSA/P margins cannot be fully resected, residual tissue can be removed by cold forceps or burned by argon plasma coagulation, and close endoscopic follow-up is advised at less than one year per the updated guidelines.

"Prophylactic clip closure reduced the risk of delayed postpolypectomy hemorrhage: experience in 277 clipped large sessile or flat colorectal lesions and 247 control lesions"

Hemorrhage (bleeding) is the most common major complication of colonoscopic polypectomy (polyp removal). The risk of hemorrhage is associated with large polyp size, proximal location, and the use of anticoagulation. One approach to prevent delayed hemorrhage after colonoscopic polypectomy is closure of polypectomy sites with clips. No controlled study has yet been reported of the value of prophylactic clip closure for the group of polyps at highest risk of complications, namely, large sessile or flat colorectal lesions.

This retrospective report from Douglas K. Rex, MD, FASGE, and colleagues at the Indiana University Hospital, Indianapolis, describes the impact of prophylactic (preventive) clip closure on complications, primarily delayed postpolypectomy hemorrhage, in 277 large polypectomy sites that were completely or partially prophylactically closed, and 247 control polypectomy sites that were not closed with clips. These lesions were removed from 463 patients who had telephone follow-up at least 30 days after colonoscopy to ensure complete capture of complications.

This study's objective was to evaluate the effect of prophylactic clip closure of polypectomy sites after resection of large (≥ 2 cm) sessile and flat colorectal lesions. The study was performed at the tertiary care endoscopy unit at Indiana University Hospital. Patients with lesions 2 cm or larger who underwent endoscopic mucosal resection (EMR) performed by using low-power coagulation current between January 2000 and February 2012 participated in the study. Beginning in June 2006, polypectomy sites were prophylactically closed with clips when possible.

The main outcome measurements were delayed hemorrhage, postpolypectomy syndrome and perforation. There were 524 lesions 2 cm or larger in 463 patients, of which 247 (47.1 percent) were not clipped, 52 (9.9 percent) were partially clipped, and 225 (42.9 percent) were fully clipped. There were 31 delayed hemorrhages, two perforations, and six cases of postpolypectomy syndrome. The delayed hemorrhage rate was 9.7 percent in the not clipped group versus 1.8 percent in the fully clipped group. Multivariate analysis showed that not clipping, location proximal to the splenic flexure and polyp size were associated with delayed bleeding.

The researchers concluded that prophylactic clipping of resection sites after endoscopic removal of large (≥ 2 cm) colorectal lesions using low-power coagulation current reduced the risk of delayed postpolypectomy hemorrhage. A randomized, prospective trial of clipping large polypectomy sites is warranted.

Guideline

Also in the issue is the updated guideline "The role of endoscopy in the assessment and treatment of esophageal cancer."


'/>"/>

Contact: Anne Brownsey
abrownsey@asge.org
630-570-5635
American Society for Gastrointestinal Endoscopy
Source:Eurekalert

Related medicine news :

1. Highlights on women, minorities and persons with disabilities in science and engineering
2. Eldon James Highlights Eco-Friendly Tubing and Fitting Assemblies at MedTec Europe
3. New IOM report highlights PEPFARs successes
4. Enhanced Microsoft SharePoint 2013 and Microsoft Office 365 Support Highlights Release of AvePoint’s DocAve 6 Service Pack 2
5. Research from the 2013 Genitourinary Cancers Symposium highlights new insights on high-risk prostate cancer prevalence and treatment, compares benefit of surveillance and surgery for management of small kidney tumors
6. Mileage Ads Highlights Publishers Can Earn More At MileageAds.com
7. Genetics Society of Americas Genetics journal highlights for February 2013
8. New study highlights Chagas disease as a growing health and socio-economic challenge
9. Mileage Ads Highlights Many Ways to Market Your Blog on a Tight Budget
10. Pulmonary & Allergy Update highlights insights and advances
11. BUSM study highlights attitudes toward HPV vaccination for boys
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... February 17, 2017 , ... Park Cities Pet Sitter President, ... on the Pet Life Radio network. The episode, which was posted this week, ... including: what factors led to Park Cities Pet Sitter’s being awarded the 2017 National ...
(Date:2/18/2017)... (PRWEB) , ... February 18, 2017 , ... ... today provides the latest information and contact points to easily connect elderly veterans ... care, assisted living, and elder-care funding. It also conveys material on this year's ...
(Date:2/17/2017)... ... February 17, 2017 , ... While EHR data has revolutionized ... an innovative workstation designed to reduce nursing fatigue while enhancing productivity. Based on ... offers a lightweight, highly mobile, multi-functional alternative to the limitations of handheld computing. ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells Pharmacy ... electronic prescribing of controlled and non-controlled substances plus the ability to manage orders ... the United States now accept electronic prescriptions, according to the Office of the ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... **An FDAnews Webinar**, Feb. 22, 2017 — 1:30 p.m. – 2:30 p.m. ... manufacturers should be asking before selecting an FDA approval pathway? , How ...
Breaking Medicine News(10 mins):
(Date:2/19/2017)... February 18, 2017 Marapharm (OTCQB: ... purchase a Medical Delivery Service with the specific and ... between qualified patients and caregivers. The delivery service is ... in the Coachella Valley, California . ... Angeles area to the West, population 19,000,000. ...
(Date:2/17/2017)... Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, Gynaecology, Musculoskeletal, ... to grow at a CAGR of 9.4% from 2017-2022 and CAGR ... a CAGR of 9.5% from 2017 to 2027. The market is ... ... you Read on to discover how you can exploit the ...
(Date:2/17/2017)... plc (NYSE, TASE: PRGO) today announced it has received final ... bitartrate and homatropine methylbromide oral solution (syrup), 5 mg/1.5 mg ... methylbromide oral solution (syrup), 5 mg/1.5 mg per 5 mL ... and children 6 years of age and older. Annual sales ... million.   ...
Breaking Medicine Technology: